Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Zeki ÖNGEN"'
Autor:
Yalın Tolga Yaylalı, Burcu Yağmur, Ümit Yaşar Sinan, Murat Meriç, İbrahim Başarıcı, Burçak Kılıçkıran avcı, Hande Şenol, Sanem Nalbantgil, Serdar Küçükoğlu, Zeki Öngen
Publikováno v:
Anatolian Journal of Cardiology, Vol 27, Iss 8, Pp 479-485 (2023)
Background: Risk assessment is recommended for patients with congenital heart disease-associated pulmonary arterial hypertension. This study aims to compare an abbreviated version of the risk assessment strategy, noninvasive French model, and an abri
Externí odkaz:
https://doaj.org/article/a8b1578742394b6fa601b5f46e5327e1
Autor:
Eser Durmaz, Bilgehan Karadağ, Deniz Mutlu, Hasan Tokdil, Zeki Öngen, Cansu Ebren, Orhan Furkan Karaca, Ali Uğur Soysal, Sinem Güral Ünal
Publikováno v:
Sakarya Tıp Dergisi, Vol 10, Iss 4, Pp 669-676 (2020)
Background In-stent restenosis(ISR) is a common angiographic finding in patients with previous stent implantation. Although the mechanism and predictors of ISR has been well-defined, after definition of neoatherosclerosis, a new perspective was emerg
Externí odkaz:
https://doaj.org/article/cd7288a712734c8f8522cd10de144962
Autor:
Eser Durmaz, Bilgehan Karadağ, Cansu Ebren, Burçak Kılıçkıran Avcı, Burak Koçak, Ece Yurtseven, Damla Koca, Utku Raimoğlu, Mehmet Semih Belpınar, Zeki Öngen
Publikováno v:
İstanbul Medical Journal, Vol 21, Iss 6, Pp 436-442 (2020)
Introduction:Atrial fibrillation (AF) is one of the most important causes of ischaemic stroke according to the TOAST classification. The CHA2DS2-VASc score is a widely used scoring system for estimating systemic thromboembolism in patients with non-v
Externí odkaz:
https://doaj.org/article/9337b3fa76f84488868063a1568e30f3
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 48, Iss 2, Pp 137-148 (2020)
Objective: The aim of this study was to examine and present the effect of statin treatment on the low-density lipoprotein (LDL) cholesterol level of patients in Turkey by evaluating the data of studies conducted in the country. Methods: Manuscripts p
Externí odkaz:
https://doaj.org/article/90dc2951f3ba4d79a2d735908369d746
Autor:
Zeki Öngen
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 46, Iss 1, Pp 1-6 (2018)
Externí odkaz:
https://doaj.org/article/5de6a2e60e984867ad1f202600c98d14
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 49, Iss 6, Pp 513-513 (2021)
Externí odkaz:
https://doaj.org/article/95ff352d024c43a9b05155e6df1bcb30
Autor:
Pınar Kızılırmak, Yağız Üresin, Oktay Özdemir, Burçak Kılıçkıran Avcı, Lale Tokgözoğlu, Zeki Öngen
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 45, Iss 1, Pp 49-66 (2017)
Objective: Hypertension is the most prevalent modifiable risk factor for cardiovascular (CV) and cerebrovascular morbidity and mortality. This study aimed to assess the effects of renin-angiotensin-aldosterone system (RAAS) blockade on CV outcomes. M
Externí odkaz:
https://doaj.org/article/3db48cbc4e1f480bb4b89d6e38e277a8
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 42, Iss 4, Pp 399-402 (2014)
Unilateral absence of the pulmonary artery and interrupted inferior vena cava are rare congenital disorders. The clinical presentation is variable, and many patients can be asymptomatic for many years and even throughout their lives. We report the ca
Externí odkaz:
https://doaj.org/article/6ed3c1f2c1624eec9cb1b27fb4c93ee1
Publikováno v:
Kardiologiia. 62:56-65
Background Studies have shown that increased body weight and obesity may be associated with an increased risk of arrhythmic events. The aim of this study was to evaluate the effect of obesity on the risk of arrhythmic events, hospitalization, and dea
Autor:
Georg Nickenig, Róbert Gábor Kiss, Zeki Öngen, Matias Nordaby, Uwe Zeymer, Gregory Y.H. Lip, Jurriën M. ten Berg, José Luis Navarro Estrada, Christopher P. Cannon, Ton Oude Ophuis, Corinna Miede, Stefan H. Hohnloser, Phillippe Gabriel Steg, Jonas Oldgren, Orly Leiva, Deepak L. Bhatt
Publikováno v:
EuroIntervention
Zeymer, U, Leiva, O, Hohnloser, S H, Steg, P G, Oldgren, J, Nickenig, G, Kiss, R G, Ongen, Z, Estrada, J N, Ophuis, T O, Lip, G Y H, Nordaby, M, Miede, C, ten Berg, J M, Bhatt, D L & Cannon, C P 2021, ' Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction : A post hoc analysis of the randomised RE-DUAL PCI trial ', EuroIntervention, vol. 17, no. 6, pp. 474-480 . https://doi.org/10.4244/EIJ-D-20-00799
Zeymer, U, Leiva, O, Hohnloser, S H, Steg, P G, Oldgren, J, Nickenig, G, Kiss, R G, Ongen, Z, Estrada, J N, Ophuis, T O, Lip, G Y H, Nordaby, M, Miede, C, ten Berg, J M, Bhatt, D L & Cannon, C P 2021, ' Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction : A post hoc analysis of the randomised RE-DUAL PCI trial ', EuroIntervention, vol. 17, no. 6, pp. 474-480 . https://doi.org/10.4244/EIJ-D-20-00799
Background: Little is known about the optimal antithrombotic therapy in patients with atrial fibrillation undergoing PCI for ST-elevation myocardial infarction (STEMI). Aims: The aim of this study was to investigate the safety and efficacy of dabigat